Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02898545 · ClinicalTrials.gov registry record · NA
Recurrent Atrial Fibrillation
A NA study, sponsored by University of Cincinnati.
- Completed
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT02898545: Completed NA study, sponsored by University of Cincinnati.
NCT02898545 is a NA study that has completed, run by University of Cincinnati. The registered enrollment target is 1 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02898545, a NA study, has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
This study will evaluate the recurrence rates of atrial fibrillation that develops in the hospital following non cardiac procedures or surgeries or acute medical illnesses.
Primary Outcome
The rate of recurrence of atrial fibrillation will be compared to the recurrence noted in the standard of care arm.
Interventions
- DEVICE SEEQ monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2016-09 |
| Est. Completion | 2017-07-20 |
| Phase | NA |
What the finished NCT02898545 record still lists
NCT02898545 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which SEEQ monitor is the first listed.
NCT02898545 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02898545 about?
NCT02898545 is a clinical study titled "Recurrent Atrial Fibrillation". This study will evaluate the recurrence rates of atrial fibrillation that develops in the hospital following non cardiac procedures or surgeries or acute medical illnesses.
What is the current status of trial NCT02898545?
This trial is currently completed. It is a NA study. The enrollment target is 1 participants. The study started on 2016-09. Estimated completion is 2017-07-20.
What interventions are being tested in trial NCT02898545?
The interventions under investigation include: SEEQ monitor (DEVICE).
Who is sponsoring clinical trial NCT02898545?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02898545's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia